(Q53532372)

15 May 2018

title

FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. (English)

1 reference

15 May 2018

author name string

Ora Israel

1

1 reference

15 May 2018

Anat Goldberg

2

1 reference

15 May 2018

Alicia Nachtigal

3

1 reference

15 May 2018

Daniela Militianu

4

1 reference

15 May 2018

Rachel Bar-Shalom

5

1 reference

15 May 2018

Zohar Keidar

6

1 reference

15 May 2018

Ignac Fogelman

7

1 reference

15 May 2018

publication date

22 June 2006

1 reference

15 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

15 May 2018

volume

33

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1280-1284

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-006-0141-3

exact match

0 references

cites work

CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.

1 reference

12 December 2020

Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy

1 reference

12 December 2020

Skeletal uptake of diphosphonate: a review

1 reference

12 December 2020

The role of nuclear medicine in monitoring treatment in skeletal malignancy.

1 reference

12 December 2020

FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma

1 reference

12 December 2020

Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

1 reference

12 December 2020

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

1 reference

12 December 2020

F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging

1 reference

12 December 2020

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

1 reference

12 December 2020

Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer

1 reference

12 December 2020

The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer

1 reference

12 December 2020

Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

1 reference

12 December 2020

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

12 December 2020

99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases

1 reference

12 December 2020

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG

1 reference

12 December 2020

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

1 reference

12 December 2020

10.1007/S00259-006-0141-3

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018